Send Message
View as an RSS Feed
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy  [View article]

    Dr. Robert Garnick is the "very 1st" reason when I decided to take a larger stake in Peregrine! He was with Genentech and brought Avastin to FDA approval... and holy Fargo cows! you remember hearing about the coding discrepancies?? I looked into it and it was "sabotage" but never once heard a word about it... !!

    I still can't believe my little stock of the century is having its day finally... ASCO 2013
    May 23, 2013. 08:49 PM | 7 Likes Like |Link to Comment
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy  [View article]
    My oh my.... Peregrines time may just have just arrived! Thanks for the article Chris! Peregrine Pharmaceuticals lead drug candidate: Bavituximab ... has been in development for years but what always attracted me to Peregrine was seeing how Peregrine let Bavi loose on many cancer indications: Lung/Breast/Pancreatic... and then when it was put up against infectious diseases..etc-- I truly thought this was going to be the stock of the century.

    Big Pharma can be tough.... but I see Big Pharma all over this little diamond in the rough.
    May 23, 2013. 08:42 PM | 7 Likes Like |Link to Comment
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel  [View article]
    Thanks for your response and although we may disagree on the trust of management, I do believe that their lead drug candidate "Bavituximab" will be trusted with investors.
    Apr 17, 2013. 06:30 PM | Likes Like |Link to Comment
  • Adam Feuerstein's Insane Obsession With Me  [View instapost]
    Great review of AF.... many of us have the same impression of him. You just gained another follower here!
    Apr 4, 2013. 01:13 AM | 2 Likes Like |Link to Comment
  • Trial News Make Peregrine Pharmaceuticals Worth Watching  [View article]
    nice to read all the positive remarks... though Peregrine had a little setback that was helped by 3rd party vendor mistakes... they are now ready for ASCO 2013.

    PPS ramping up till then
    Mar 21, 2013. 01:32 PM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel  [View article]
    Dr. Schwartz... have you invested in Peregrine since this article was posted? the short term period is over... 72 hours I believe you stated and am very curious if you have invested in Peregrine Pharmaceuticals since you've written this article.

    Mar 21, 2013. 12:45 PM | Likes Like |Link to Comment
  • Peregrine's Lung Cancer Drug Has Promising Trial  [View article]
    Looks like Peregrine will be back on the talking block for the next 90 days leading up to ASCO and post ASCO. Lots of data coming out and now since there is "clear evidence of dose switching" at CSM in Fargo, ND.... the word is spreading that someone was holding back Bavituximab. Federal Investigations have been continuing as Peregrine has salvaged the trial data that strongly supports moving to Phase III. Breakthrough Designation is being weighed as a possibility as Bavi is showing to work better than Avastin and clearly the better safety profile.
    Mar 19, 2013. 10:45 PM | Likes Like |Link to Comment
  • Peregrine Releases Earnings, But The Situation Remains The Same  [View article]
    I'd like to make one point from your quote: "Peregrine was still held a very bad reputation due to its botched phase II trial and other giant setbacks it saw in its past."

    .. its botched phase II trial = implies that Peregrine was at fault. CEO Steve King clearly stated: "Clear Evidence of Dose Switching" at CSM in Fargo, ND. If proper checking on the story you'd find out that Peregrine has moved into "mediation" with CSM as of March 8th, 2013 and there is an ongoing Federal Investigation. These facts are the reason why Peregrine has a following of investors that don't throw in the towel on the future of Bavituximab.
    Mar 14, 2013. 02:10 AM | 2 Likes Like |Link to Comment
  • Peregrine Pharmaceuticals (PPHM) dips 6.5% in post-session trading after filing a $75M at-the-market secondary sales agreement with MLV & Company.  [View news story]
    Peregrine getting ready for a major Partnering deal? Its the only reasonable explanation. No other reason they needed to do this at this time and leverage with partner(s) ? Time will tell
    Dec 29, 2012. 07:10 AM | Likes Like |Link to Comment
  • PPHM. A little pharma gem and should be a true buyout. Real products an a bunch is trial stage !   [View instapost]
    Peregrine in its final stage of gaining "complete" leverage once median overall survival proves to beat standard of care. Partnering is the most likely scenario but a buyout is still a good possibility as many big pharmas are going to be going fishing to see how much bait it would take to reel this once speculative stock turned big fish .... into their ship for many years of good eating!
    Dec 15, 2012. 04:02 AM | Likes Like |Link to Comment
  • More Downside Expected In Peregrine Pharmaceuticals  [View article]
    Well... lots has been said regarding Peregrine and after looking at all the information and the potential, I would say Peregrine will be the stock of the century and the best unpartnered bio stock in the industry!
    Aug 31, 2012. 07:06 AM | Likes Like |Link to Comment